White
 GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998;39
(2, pt 3)
S34-Â S37
Goulden
 V, Stables
 GI, Cunliffe
 WJ. Prevalence of facial acne in adults. J Am Acad Dermatol. 1999;41577- 580
Cunliffe
 WJ, Gould
 DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. BMJ. 1979;11109- 1110
Rademaker
 M, Garioch
 JJ, Simpson
 NB. Acne in schoolchildren: no longer a concern for dermatoloigsts. BMJ. 1989;2981217- 1219
Kilkenny
 M, Merlin
 K, Plunkett
 A, Marks
 R. The prevalence of common skin conditions in Australian school students, III: acne vulgaris. Br J Dermatol. 1998;139840- 845
Lello
 J, Pearl
 A, Arroll
 B, Yallop
 J, Birchall
 NM. Prevalence of acne vulgaris in Auckland senior high school students. N Z Med J. 1995;108287- 289
Schaefer
 O. When the Eskimo comes to town. Nutr Today. 1971;68- 16
Steiner
 PE. Necropsies on Okinawans: anatomic and pathologic observations. Arch Pathol. 1946;42359- 380
Bechelli
 LM, Haddad
 N, Pimenta
 WP.
 et al.  Epidemiological survey of skin diseases in schoolchildren living in the Purus Valley (Acre State, Amazonia, Brazil). Dermatologica. 1981;16378- 93
Freyre
 EA, Rebaza
 RM, Sami
 DA, Lozada
 CP. The prevalence of facial acne in Peruvian adolescents and its relation to their ethnicity. J Adolesc Health. 1998;22480- 484
Park
 RG. The age distribution of common skin disorders in the Bantu of Pretoria, Transvaal. Br J Dermatol. 1968;80758- 761
Findlay
 GH. The age incidence of common skin diseases in the white population of the Transvaal. Br J Dermatol. 1967;79538- 542
Cunliffe
 WJ, Cotterill
 JA,  The acnes: clinical features, pathogenesis and treatment. Rook
 A.ed.Major Problems in Dermatology Philadelphia, Pa WB Saunders Co1975;13- 14
Lindeberg
 S, Lundh
 B. Apparent absence of stroke and ischaemic heart disease in a traditional Melanesian island: a clinical study in Kitava. J Intern Med. 1993;233269- 275
Lindeberg
 S, Nilsson-Ehle
 P, Terént
 A, Vessby
 B, Scherstén
 B. Cardiovascular risk factors in a Melanesian population apparently free from stroke and ischaemic heart disease: the Kitava Study. J Intern Med. 1994;236331- 340
Lindeberg
 S, Eliasson
 M, Lindahl
 B, Ahrén
 B. Low serum insulin in traditional Pacific Islanders: the Kitava Study. Metabolism. 1999;481216- 1219
Lindeberg
 S, Berntorp
 E, Carlsson
 R, Eliasson
 M, Marckmann
 P. Haemostatic variables in Pacific Islanders apparently free from stroke and ischaemic heart disease. Thromb Haemost. 1997;7794- 98
Lindeberg
 S, Soderberg
 S, Ahren
 B, Olsson
 T. Large differences in serum leptin levels between nonwesternized and westernized populations: the Kitava Study. J Intern Med. 2001;249553- 558
Schiefenhövel
 W, Bell-Krannhals
 I. Wer teilt, hat teil an der macht: Systeme der yams-vergabe auf den Trobriand Inseln, Papua-Neuguinea. Mitt Anthropol Gesell Wien. 1986;11619- 39
Hawkes
 K, Kaplan
 H, Hill
 K, Hurtado
 M. Aché at the settlement: contrasts between farming and foraging. Hum Ecol. 1987;15133- 161
Hurtado
 AM, Hill
 K, Kaplan
 H, Hurtado
 I. Tradeoffs between female food acquisition and child care among Hiwi and Aché foragers. Hum Nature. 1992;3185- 216
Hill
 K, Hurtado
 AM. Aché Life History: The Ecology and Demography of a Foraging People. New York, NY Aldine de Gruyter1996;
Gurven
 M, Allen-Arave
 W, Hill
 K, Hurtado
 AM. "It's a wonderful life": signaling generosity among the Aché of Paraguay. Evol Hum Behav. 2000;21263- 282
Hurtado
 AM, Hill
 KR, Rosenblatt
 W, Bender
 J, Scharmen
 T. A longitudinal study of tuberculosis outcomes among immunologically naïve Aché natives of Paraguay. Am J Phys Anthropol. In press
McMillan
 G. Ache Residential Grouping and Social Foraging [dissertation]. Albuquerque University of New Mexico2001;
Kaplan
 H, Hill
 K, Lancaster
 J, Hurtado
 AM. The evolution of intelligence and the human life history. Evol Anthropol. 2000;9156- 184
Pochi
 PE, Shalita
 AR, Strauss
 JS.
 et al.  Report of the Consensus Conference on Acne Classification: Washington, DC, March 24 and 25, 1990. J Am Acad Dermatol. 1991;24495- 500
Goulden
 V, McGeown
 CH, Cunliffe
 WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol. 1999;141297- 300
Walton
 S, Wyat
 EH, Cunliffe
 WJ. Genetic control of sebum excretion and acne: a twin study. Br J Dermatol. 1989;121144- 145
Fleischer
 AB, Feldman
 SR, Bradham
 DD. Office-based physician services provided by dermatologists in the United States in 1990. J Invest Dermatol. 1994;10293- 97
Eichenfield
 LF, Leyden
 JJ. Acne: current concepts of pathogenesis and approach to rational treatment. Pediatrician. 1991;18218- 223
Thiboutot
 DM. Acne: an overview of clinical research findings. Dermatol Clin. 1997;1597- 109
Webster
 GF. Acne vulgaris: state of the science. Arch Dermatol. 1999;1351101- 1102
Green
 J, Sinclair
 RD. Perceptions of acne vulgaris in final-year medical student written examination answers. Australas J Dermatol. 2001;4298- 101
Holt
 SA, Brand Miller
 JC, Petocz
 P. An insulin index of foods: the insulin demand generated by 100-kJ portions of common foods. Am J Clin Nutr. 1997;661264- 1276
Daly
 ME, Vale
 C, Walker
 M, Alberti
 KG, Mathers
 JC. Dietary carbohydrates and insulin sensitivity: a review of the evidence and clinical implications. Am J Clin Nutr. 1997;661072- 1085
Zammit
 VA, Waterman
 IJ, Topping
 D, McKay
 G. Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J Nutr. 2001;1312074- 2077
Nam
 SY, Lee
 EJ, Kim
 KR.
 et al.  Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord. 1997;21355- 359
Attia
 N, Tamborlane
 WV, Heptulla
 R.
 et al.  The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab. 1998;831467- 1471
Brismar
 K, Fernqvist-Forbes
 E, Wahren
 J, Hall
 K. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-1 in insulin-dependent diabetes. J Clin Endocrinol Metab. 1994;79872- 878
Holly
 JMP. The physiological role of IGFBP-1. Acta Endocrinol. 1991;12455- 62
Ferry
 RJ, Cerri
 RW, Cohen
 P. Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res. 1999;5153- 67
Rudman
 SM, Philpott
 MP, Thomas
 GA, Kealey
 T. The role of IGF-I in human skin and its appendages: morphogen as well as mitogen? J Invest Dermatol. 1997;109770- 777
Bol
 KK, Kiguchi
 K, Gimenez-Conti
 I, Rupp
 T, DiGiovanni
 J. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene. 1997;141725- 1734
Aizawa
 H, Niimura
 M. Elevated serum insulin-like growth factor-I (IGF-1) levels in women with postadolescent acne. J Dermatol. 1995;22249- 252
Aizawa
 H, Niimura
 M. Mild insulin resistance during oral glucose tolerance test (OGTT) in women with acne. J Dermatol. 1996;23526- 529
Liu
 VR. The Glycaemic Index and the Insulin-Like Growth Factor System [honors thesis]. Sydney, Australia Human Nutrition Unit, Dept of Biochemistry, University of Sydney2000;
Valentinis
 B, Bhala
 A, DeAngelis
 T, Baserga
 R, Cohen
 P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol. 1995;9361- 367
Vacaresse
 N, Lajoie-Mazenc
 I, Auge
 N.
 et al.  Activation of epithelial growth factor receptor pathway by unsaturated fatty acids. Circ Res. 1999;85892- 899
Schleicher
 ED, Weigert
 C. Role of the hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int Suppl. 2000;77S13- S18
Edmondson
 SR, Murashita
 MM, Russo
 VC, Wraight
 CJ, Werther
 GA. Expression of insulin-like growth factor binding protein-3 (IGFBP-3) in human keratinocytes is regulated by EGF and TGFβ1. J Cell Physiol. 1999;179201- 207
Evans
 TR, Kaye
 SB. Retinoids: present role and future potential. Br J Cancer. 1999;801- 8
Yang
 Q, Mori
 I, Shan
 L.
 et al.  Biallelic inactivation of retinoic acid receptor B2 gene by epigenetic change in breast cancer. Am J Pathol. 2001;158299- 303
Liu
 B, Lee
 HY, Weinzimer
 SA.
 et al.  Direct functional interaction between insulin-like growth factor-binding protein-3 and retionoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem. 2000;27533607- 33613
Wendling
 O, Chambon
 P, Mark
 M. Retinoid X receptors are essential for early mouse development and placentogenesis. Proc Natl Acad Sci U S A. 1999;96547- 551
Chiba
 H, Clifford
 J, Metzger
 D, Chambon
 P. Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells. Mol Cell Biol. 1997;173013- 3020
Grimberg
 A, Cohen
 P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol. 2000;1831- 9
Thacher
 SM, Vasudevan
 J, Chandraratna
 RA. Therapeutic applications for ligands of retinoid receptors. Curr Pharm Des. 2000;625- 58
Barbieri
 RL, Smith
 S, Ryan
 KJ. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 1988;50197- 212
Cara
 JF. Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm Res. 1994;4249- 54
Bebakar
 WM, Honour
 JW, Foster
 D, Liu
 YL, Jacobs
 HS. Regulation of testicular function by insulin and transforming growth factor-beta. Steroids. 1990;55266- 270
De Mellow
 JS, Handelsman
 DJ, Baxter
 RC. Short-term exposure to insulin-like growth factors stimulates testosterone production by testicular interstitial cells. Acta Endocrinol. 1987;115483- 489
Crave
 JC, Lejeune
 H, Brebant
 C, Baret
 C, Pugeat
 M. Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (Hep G2) cells. J Clin Endocrinol Metab. 1995;801283- 1289
Singh
 A, Hamilton-Fairley
 D, Koistinen
 R.
 et al.  Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol. 1990;124R1- R3
Pugeat
 M, Crave
 JC, Elmidani
 M.
 et al.  Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol. 1991;40841- 849
Vermeulen
 A, Kaufman
 JM, Giagulli
 VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab. 1996;811821- 1826
Pfeilschifter
 J, Scheidt-Nave
 C, Leidig-Bruckner
 G.
 et al.  Relationship between circulating insulin-like growth factor components and sex hormones in a population-based sample of 50- to 80-year-old men and women. J Clin Endocrinol Metab. 1996;812534- 2540
Erfurth
 EM, Hagmar
 LE, Saaf
 M, Hall
 K. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men. Clin Endocrinol (Oxf). 1996;44659- 664
Zouboulis
 CC, Xia
 L, Akamatsu
 H.
 et al.  The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology. 1998;19621- 31
Deplewski
 D, Rosenfield
 RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology. 1999;1404089- 4094
Klinger
 B, Anin
 S, Silbergeld
 A, Eshet
 R, Laron
 Z. Development of hyperandrogenism during treatment with insulin-like growth hormone factor-I (IGF-I) in female patients with Laron syndrome. Clin Endocrinol (Oxf). 1998;4881- 87
Thiboutot
 D, Gilliland
 K, Light
 J, Lookingbill
 D. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol. 1999;1351041- 1045
Falsetti
 L, Eleftheriou
 G. Hyperinsulinemia in the polycystic ovary syndrome: a clinical endocrine and echographic study in 240 patients. Gynecol Endocrinol. 1996;10319- 326
Nestler
 JE. Insulin regulation of human ovarian androgens. Hum Reprod. 1997;12
(suppl 1)
53-Â 62
Thierry van Dessel
 HJ, Lee
 PD, Faessen
 G, Fauser
 BC, Giudice
 LC. Elevated serum levels of free insulin-like growth factor-I levels in polycystic ovary syndrome. J Clin Endocrinol Metab. 1999;843030- 3035
Pasquali
 R, Casimirri
 F, Vicennati
 V. Weight control and its beneficial effect on fertility in women with obesity and polycystic ovary syndrome. Hum Reprod. 1997;12
(suppl 1)
82-Â 87
Ehrmann
 DA. Insulin-lowering therapeutic modalities for polycystic ovary syndrome. Endocrinol Metab Clin North Am. 1999;28423- 438
Cohen
 JL, Cohen
 AD. Pustular acne, staphyloderma and its treatment with tolbutamide. CMAJ. 1959;80629- 632
Bettley
 FR. The treatment of acne vulgaris with tolbutamide. Br J Dermatol. 1961;73149- 151
Singh
 I, Gaind
 ML, Jayram
 D. Tolbutamide in the treatment of skin diseases. Br J Dermatol. 1961;73362- 366
Daniel
 M, Rowley
 KG, McDermott
 R, Mylvaganam
 A, O'Dea
 K. Diabetes incidence in an Australian aboriginal population: an 8-year follow-up study. Diabetes Care. 1999;221993- 1998
Ebbesson
 SO, Schraer
 CD, Risica
 PM.
 et al.  Diabetes and impaired glucose tolerance in three Alaskan Eskimo populations: the Alaska-Siberia Project. Diabetes Care. 1998;21563- 569
Merimee
 TJ, Rimoin
 DL, Cavalli-Sforza
 LL. Metabolic studies in the African Pygmy. J Clin Invest. 1972;51395- 401
O'Dea
 K. Marked improvement in carbohydrate and lipid metabolism in diabetic Australian Aborigines after temporary reversion to traditional lifestyle. Diabetes. 1984;33596- 603
Mouratoff
 GJ, Scott
 EM. Diabetes mellitus in Eskimos after a decade. JAMA. 1973;2261345- 1346
Spielman
 RS, Fajans
 SS, Neel
 JV, Pek
 S, Floyd
 JC, Oliver
 WJ. Glucose tolerance in two unacculturated Indian tribes of Brazil. Diabetologia. 1982;2390- 93
Salmeron
 J, Ascherio
 A, Rimm
 EB.
 et al.  Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care. 1997;20545- 550
Frost
 G, Leeds
 A, Trew
 G, Margara
 R, Dornhorst
 A. Insulin sensitivity in women at risk of coronary heart disease and the effects of a low glycemic diet. Metabolism. 1998;471245- 1251
Berrino
 F, Bellati
 C, Secreto
 G.
 et al.  Reducing bioavailable sex hormones through a comprehensive change in diet: the Diet and Androgens (DIANA) Randomized Trial. Cancer Epidemiol Biomarkers Prev. 2001;1025- 33